USD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -12.13 Thousand USD | 7.85% |
2022 | -13.47 Thousand USD | -5.16% |
2021 | - USD | -9.94% |
2020 | - USD | 0.0% |
2019 | -1475.00 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -10.13 Thousand USD | -12.77% |
2024 Q2 | -19.99 Thousand USD | -1044.05% |
2023 Q4 | -11.21 Thousand USD | 25.24% |
2023 FY | - USD | 7.85% |
2023 Q3 | -15 Thousand USD | 27.15% |
2023 Q2 | -20.6 Thousand USD | -82.54% |
2023 Q1 | -11.28 Thousand USD | -640.97% |
2022 Q3 | -2456.00 USD | 0.0% |
2022 FY | - USD | -5.16% |
2022 Q4 | -1523.00 USD | 37.99% |
2021 FY | - USD | -9.94% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Bio Medica Corporation | -1.16 Million USD | 98.957% |
Arrayit Corporation | -3.07 Million USD | 99.606% |
Atlantic International Corp. | -5.38 Million USD | 99.775% |
Biocept, Inc. | -30.24 Million USD | 99.96% |
Bioqual, Inc. | 3.03 Million USD | 100.4% |
CardioGenics Holdings Inc | -757.37 Thousand USD | 98.398% |
DermTech, Inc. | -97.89 Million USD | 99.988% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.0% |
HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 99.94% |
iMD Companies, Inc. | -154.65 Thousand USD | 92.154% |
IDenta Corp. | 71.58 Thousand USD | 116.95% |
Interpace Biosciences, Inc. | 3.83 Million USD | 100.316% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | 131.362% |
InVitro International | 6680.00 USD | 281.647% |
Lumos Diagnostics Holdings Limited | -5.43 Million USD | 99.777% |
Medical Imaging Corp. | -896.74 Thousand USD | 98.647% |
NovelStem International Corp. | -3.78 Million USD | 99.679% |
Optigenex Inc. | -1.18 Million USD | 98.978% |
PharmChem, Inc. | 1.05 Million USD | 101.151% |
Proteome Sciences plc | -1.13 Million USD | 98.933% |
Response Genetics, Inc | -19.66 Million USD | 99.938% |
Rennova Health, Inc. | -234.81 Thousand USD | 94.833% |
RushNet, Inc. | -614.85 Thousand USD | 98.027% |
ScreenPro Security Inc. | -3.43 Million USD | 99.647% |
Stella Diagnostics Inc. | -5.7 Million USD | 99.787% |
StageZero Life Sciences Ltd. | -10.27 Million USD | 99.882% |
Todos Medical Ltd. | -9.39 Million USD | 99.871% |